Sunita Shinde, MD

Efficacy of Monthly Extended-release Risperidone Injections (RBP-7000) for the Treatment of Schizophrenia: An Analysis of Individual PANSS Items

Introduction: RBP-7000 (PERSERIS™) is a once-monthly, subcutaneous, extended-release risperidone formulation that is approved for treating schizophrenia in adults and is designed to deliv...

Anne Andorn , MD;

James Graham , PharmD, BS Pharm, RPh;

Maurizio Fava , MD, PhD;

John Csernansky , MD;

John Newcomer , MD;

Sunita Shinde , MD;

Gilbert Muma , PhD;

Christian Heidbreder , PhD;

David Walling , PhD, CNS, MD;

11/22/2019

RBP-7000 for the Treatment of Schizophrenia: Efficacy and Safety Results From Two Phase III Trials

Introduction: RBP-7000 is a subcutaneously administered, once-monthly, extended-release depot formulation of risperidone designed to achieve therapeutic concentrations without supplementa...